Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-09
2011-08-09
Loewe, Sun Jae (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S400000
Reexamination Certificate
active
07994209
ABSTRACT:
In one aspect, the invention relates to compounds of formula I:where R1-6are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin and norepinephrine reuptake inhibitors. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.
REFERENCES:
patent: 3634437 (1972-01-01), Todd
patent: 4229449 (1980-10-01), Melloni et al.
patent: 4243807 (1981-01-01), Friebe et al.
patent: 5023269 (1991-06-01), Robertson et al.
patent: 5037841 (1991-08-01), Schobe et al.
patent: 5614518 (1997-03-01), Leeson et al.
patent: 6518284 (2003-02-01), Venero et al.
patent: 7294637 (2007-11-01), Aquila et al.
patent: 7317011 (2008-01-01), Wong et al.
patent: 7378436 (2008-05-01), Fish et al.
patent: 7384941 (2008-06-01), Walter et al.
patent: 2002/0151712 (2002-10-01), Lin et al.
patent: 2005/0245519 (2005-11-01), Barta et al.
patent: 2005/0250775 (2005-11-01), Fish et al.
patent: 2007/0015786 (2007-01-01), Allen et al.
patent: 2007/0072859 (2007-03-01), Boulet et al.
patent: 2007/0265306 (2007-11-01), Venero et al.
patent: 2010/0022616 (2010-01-01), Stangeland et al.
patent: 2010/0261762 (2010-10-01), Dreyfus et al.
patent: WO 2007/031828 (2007-03-01), None
patent: WO 2008/023258 (2008-02-01), None
Alzheimer's Disease Treatment Phases, http://www.alzheimerstreatment.org/treatment/disease-treatment.htm (2008).
Alzheimer's Drugs, Consumer Reports Best Buy Drugs (p. 1-5) 2002.
U.S. Appl. No. 12/760,276, Stangeland et al.
Fish et al., “Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition”, Bioorganic & Medicinal Chemistry Letters, 18, pp. 2562-2566, 2008.
Fish et al., “Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity”, Bioorganic & Medicinal Chemistry Letters, 18, pp. 4355-4359, 2008.
Fish et al., “4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: Design, synthesis and structure-activity relationships”, Bioorganic & Medicinal Chemistry Letters, 19, pp. 2829-2834, 2009.
Melloni et al., “Potential antidepressant agents. Alpha-aryloxy-benzyl derivatives of ethanolamine and morpholine”, European Journal of Medicinal Chemistry, 19(3), pp. 235-242, 1984.
Orjales et al., “Synthesis and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters”, Journal of Medicinal Chemistry, 46, pp. 5512-5532, 2003.
PCT International Search Report for International application No. PCT/US2010/041654.
Russell, J. et al., “Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial”, Pain, 136 (2008), pp. 432-444.
Vitton, O. et al., “A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia”, Human Psychopharmacology, 19 (2004), pp. S27-S35.
Hughes Adam
Patterson Lori Jean
Saito Daisuke Roland
Schmidt Jane
Strangeland Eric
Eberle Shelley
Hagenah Jeffrey A.
Loewe Sun Jae
Theravance Inc.
LandOfFree
3-phenoxymethylpyrrolidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-phenoxymethylpyrrolidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-phenoxymethylpyrrolidine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2720554